Summary:
Clinical research study of an investigational medication on slowing progression of Mild Cognitive Impairment due to Alzheimer's disease.
Qualified Participants Must:
• Be between 55 and 85 years of age in good general health
•
Have a study partner who can accompany subject to all clinic visits
•
Have Mild Cognitive Impairment
•
Cognitive decline NOT primarily caused by vascular, traumatic, or medical problems
Qualified Participants May Receive:
- All study medication and procedures at no cost
- Compensation for time and travel